@ARTICLE{
author={O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana},
year={2025},
title={Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study},
journal={CLINICAL BREAST CANCER},
volume={25},
number={6},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 34)},
year={2025},
title={Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer},
journal={NEW ENGLAND JOURNAL OF MEDICINE},
volume={392},
number={3},
pages={249-257},
document_type={Article},
} 

@ARTICLE{
author={Geyer Jr Charles E,...,Stamatovic Ljiljana,...,(broj koautora 35)},
year={2025},
title={Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer},
journal={NEW ENGLAND JOURNAL OF MEDICINE},
volume={},
number={},
pages={-},
document_type={Article; Early Access},
} 

@ARTICLE{
author={O'Shaughnessy Joyce,...,Cvetanovic Ana S,...,Stamatovic Ljiljana},
year={2021},
title={Original Research Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study},
journal={EUROPEAN JOURNAL OF CANCER},
volume={152},
number={},
pages={223-232},
document_type={Article},
} 

@ARTICLE{
author={Belkacemi Yazid,...,Tesanovic Dusanka D,...,Popovic Lazar S,...,Kovcin Vladimir N,...,Dzodic Radan R,Markovic Ivan Z,Vasovic Suzana,Stamatovic Ljiljana,Radosavljevic Davorin Z,Radulovic Sinisa S,...,(broj koautora 48)},
year={2020},
title={A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries},
journal={EUROPEAN JOURNAL OF CANCER},
volume={135},
number={},
pages={130-146},
document_type={Review},
} 

@ARTICLE{
author={Conte Pier Franco,...,Stamatovic Ljiljana,...,(broj koautora 21)},
year={2020},
title={Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer},
journal={CANCER},
volume={126},
number={13},
pages={3132-3139},
document_type={Article},
} 

@ARTICLE{
author={Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65)},
year={2019},
title={AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)},
journal={JOURNAL OF BUON},
volume={24},
number={5},
pages={2180-2197},
document_type={Article},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Susnjar Snezana V,Gavrilovic Dusica,Minic Ivana Z,Ursulovic Tamara B,Dzodic Radan R},
year={2018},
title={The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients},
journal={JOURNAL OF BUON},
volume={23},
number={5},
pages={1273-1280},
document_type={Article},
} 

@ARTICLE{
author={Bosnjak Snezana M,Stamatovic Ljiljana,Borroni Maria Elisa,Rizzi Giada,Jordan Karin},
year={2018},
title={Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy},
journal={INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER},
volume={28},
number={6},
pages={1153-1161},
document_type={Article},
} 

@ARTICLE{
author={Krivokuca Ana M,Dragos Vita Setrajcic,Stamatovic Ljiljana,Blatnik Ana,Boljevic Ivana Z,Stegel Vida,Rakobradovic Jelena D,Skerl Petra,Jovandic Stevo,Krajc Mateja,Brankovic-Magic Mirjana V,Novakovic Srdjan},
year={2018},
title={Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin},
journal={FAMILIAL CANCER},
volume={17},
number={2},
pages={179-185},
document_type={Article},
} 

@ARTICLE{
author={Popovic Lazar S,Tomasevic Zorica I,Stamatovic Ljiljana,Markovic Ivan Z,Matovina-Brko Gorana G,Buta Marko N,Golubovic Andrija,Selakovic Vladimir,Trifunovic Jasna D,Mutrezani Zafir,Ivanovic Nebojsa S,Nedovic Jasmina R,Ninkovic Srdjan M,Filipovic Sladjana,Cvetanovic Ana S,Djordjevic Nebojsa P,Karanikolic Aleksandar D,Ivkovic-Kapicl Tatjana V,Vicko Ferenc},
year={2018},
title={Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE},
journal={JOURNAL OF BUON},
volume={23},
number={2},
pages={522-532},
document_type={Article},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Vasovic Suzana,Trifunovic Jasna D,Boskov Nedeljka,Gajic Z,Parezanovic A,Icevic M,Cirkovic Andja M,Milic Natasa M},
year={2018},
title={Factors influencing time to seeking medical advice and onset of treatment in women who are diagnosed with breast cancer in Serbia},
journal={PSYCHO-ONCOLOGY},
volume={27},
number={2},
pages={576-582},
document_type={Article},
} 

@ARTICLE{
author={Pljesa Igor,Berisavac Milica,Simic Tatjana P,Pekmezovic Tatjana D,Coric Vesna M,Suvakov Sonja R,Stamatovic Ljiljana,Matic Marija G,Gutic Bojana,Milenkovic Sanja M,Pljesa-Ercegovac Marija S,Savic-Radojevic Ana R},
year={2017},
title={Polymorphic expression of glutathione transferases A1, M1, P1 and T1 in epithelial ovarian cancer: a Serbian case-control study},
journal={JOURNAL OF BUON},
volume={22},
number={1},
pages={72-79},
document_type={Article},
} 

@ARTICLE{
author={Jassem Jacek,Ozmen Vahit,Bacanu Florin,Drobniene Monika,Eglitis Janis,Lakshmaiah Kuntegowdanahalli C,Kahan Zsuzsanna,Mardiak Jozef,Pienkowski Tadeusz,Semiglazova Tatiana,Stamatovic Ljiljana,Timcheva Constanta,Vasovic Suzana,Vrbanec Damir,Zaborek Piotr},
year={2014},
title={Delays in diagnosis and treatment of breast cancer: a multinational analysis},
journal={EUROPEAN JOURNAL OF PUBLIC HEALTH},
volume={24},
number={5},
pages={761-767},
document_type={Article},
} 

@ARTICLE{
author={Abu Rabi Zaki,Todorovic-Rakovic Natasa,Markicevic Milan A,Stamatovic Ljiljana,Vujasinovic Tijana,Nikolic-Vukosavljevic Dragica},
year={2013},
title={Change of influence of prognostic markers on metastasis free interval during and after adjuvant tamoxifen therapy in breast cancer patients},
journal={JOURNAL OF BUON},
volume={18},
number={2},
pages={321-327},
document_type={Article},
} 

@ARTICLE{
author={Konjevic Gordana M,Radenkovic Sandra S,Srdic Tatjana V,Jurisic Vladimir B,Stamatovic Ljiljana,Milovic Marijana M},
year={2011},
title={Association of decreased NK cell activity and IFN gamma expression with pSTAT dysregulation in breast cancer patients},
journal={JOURNAL OF BUON},
volume={16},
number={2},
pages={219-226},
document_type={Article},
} 

@ARTICLE{
author={Milovic-Kovacevic Marijana M,Stamatovic Ljiljana,Popov Ivan P,Radosevic-Jelic Ljiljana M,Kezic Iva},
year={2010},
title={Platinum - sensitive relapsed epithelial ovarian cancer: Not all the patients benefit from reinduction with carboplatin and paclitaxel},
journal={MEDICAL SCIENCE MONITOR},
volume={16},
number={11},
pages={CR549-CR554},
document_type={Article},
} 

@ARTICLE{
author={Abu Rabi Zaki,Markicevic Milan A,Vujasinovic Tijana,Lukic Silvana T,Stamatovic Ljiljana,Nikolic-Vukosavljevic Dragica},
year={2010},
title={Early and Late Tamoxifen Resistance in Breast Cancer},
journal={ARCHIVES OF BIOLOGICAL SCIENCES},
volume={62},
number={2},
pages={249-256},
document_type={Article},
} 

@ARTICLE{
author={Tomasevic Zorica I,Jelic Svetislav B,Nikolic L,Filipovic I,Stamatovic Ljiljana,Radosavljevic Davorin Z},
year={2003},
title={Negative CEA values in metastatic colorectal carcinoma and the likelihood of complete chemotherapy response},
journal={INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS},
volume={18},
number={1},
pages={28-32},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Stamatovic Ljiljana,Vucicevic Slavko S,Petrovic Zeljko M,Kreacic Miroslav,Babovic Nada Lj,Jovanovic Natasa,Mikic Anton A,Gavrilovic Dusica},
year={2002},
title={Use of high-dose cytarabine to enhance cisplatin cytotoxicity - effects on the response and overall survival rates of advanced head and neck cancer patients},
journal={EUROPEAN JOURNAL OF CANCER},
volume={38},
number={11},
pages={1478-1489},
document_type={Article},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Kreacic Miroslav,Matkovic Suzana V,Popov Ivan P},
year={2001},
title={Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study},
journal={MEDICAL ONCOLOGY},
volume={18},
number={3},
pages={189-195},
document_type={Article},
} 

@ARTICLE{
author={Susnjar Snezana V,Vasovic Suzana,Neskovic-Konstantinovic Zora B,Stamatovic Ljiljana,Lukic Vesna,Colakovic Slobodanka,Mitrovic LB,Jelic Svetislav B,Radulovic Sinisa S},
year={1999},
title={Mitoxantrone, 5-fluorouracil and low-dose leucovorin in doxorubicin-resistant advanced breast cancer patients: A phase II study},
journal={TUMORI},
volume={85},
number={6},
pages={478-482},
document_type={Article},
}